162 related articles for article (PubMed ID: 19620053)
1. [Changes of mast cells and gut hormones in rats with TNBS-induced ulcerative colitis].
Zhao P; Dong L; Luo JY; Guan HT; Ma H; Wang XQ
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jul; 29(7):1359-63. PubMed ID: 19620053
[TBL] [Abstract][Full Text] [Related]
2. Possible role of mast cells and neuropeptides in the recovery process of dextran sulfate sodium-induced colitis in rats.
Zhao P; Dong L; Luo JY; Guan HT; Ma H; Wang XQ
Chin Med Sci J; 2013 Mar; 28(1):28-33. PubMed ID: 23527803
[TBL] [Abstract][Full Text] [Related]
3. Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis.
Del Valle-Pinero AY; Sherwin LB; Anderson EM; Caudle RM; Henderson WA
World J Gastroenterol; 2015 Jan; 21(1):155-63. PubMed ID: 25574088
[TBL] [Abstract][Full Text] [Related]
4. Substance P--an underlying factor for pouchitis? Prospective study of substance P- and vasoactive intestinal polypeptide-immunoreactive innervation and mast cells.
Keränen U; Järvinen H; Kärkkäinen P; Kiviluoto T; Kivilaakso E; Soinila S
Dig Dis Sci; 1996 Aug; 41(8):1665-71. PubMed ID: 8769299
[TBL] [Abstract][Full Text] [Related]
5. Recombinant expressed vasoactive intestinal peptide analogue ameliorates TNBS-induced colitis in rats.
Xu CL; Guo Y; Qiao L; Ma L; Cheng YY
World J Gastroenterol; 2018 Feb; 24(6):706-715. PubMed ID: 29456409
[TBL] [Abstract][Full Text] [Related]
6. Role of mast cells and eosinophils in different stages of trinitrobenzenosulphonic acid-induced rat colitis.
Zhao P; Guan H; Dong L; Luo J; Gong J
Int J Clin Exp Pathol; 2019; 12(2):498-506. PubMed ID: 31933854
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of intestinal mucosal mast cells expressing VPAC1 in close proximity to vasoactive intestinal polypeptide in inflammatory bowel disease and murine colitis.
Casado-Bedmar M; Heil SDS; Myrelid P; Söderholm JD; Keita ÅV
Neurogastroenterol Motil; 2019 Mar; 31(3):e13503. PubMed ID: 30407703
[TBL] [Abstract][Full Text] [Related]
8. Substance P- and vasoactive intestinal polypeptide-immunoreactive innervation in normal and inflamed pouches after restorative proctocolectomy for ulcerative colitis.
Keränen U; Järvinen H; Kiviluoto T; Kivilaakso E; Soinila S
Dig Dis Sci; 1996 Aug; 41(8):1658-64. PubMed ID: 8769298
[TBL] [Abstract][Full Text] [Related]
9. Long-term study of TNBS-induced colitis in rats: focus on mast cells.
Menozzi A; Pozzoli C; Poli E; Lazzaretti M; Grandi D; Coruzzi G
Inflamm Res; 2006 Oct; 55(10):416-22. PubMed ID: 17109068
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect and mechanism of proanthocyanidins from grape seeds in rats with TNBS-induced ulcerative colitis.
Li XL; Cai YQ; Qin H; Wu YJ
Can J Physiol Pharmacol; 2008 Dec; 86(12):841-9. PubMed ID: 19088805
[TBL] [Abstract][Full Text] [Related]
11. Neuroimmune interactions in experimental colitis. An immunoelectron microscopic study.
Fehér E; Altdorfer K; Bagaméri G; Fehér J
Neuroimmunomodulation; 2001; 9(5):247-55. PubMed ID: 11964519
[TBL] [Abstract][Full Text] [Related]
12. Regulatory mechanism of electroacupuncture in irritable bowel syndrome: preventing MC activation and decreasing SP VIP secretion.
Wu HG; Jiang B; Zhou EH; Shi Z; Shi DR; Cui YH; Kou ST; Liu HR
Dig Dis Sci; 2008 Jun; 53(6):1644-51. PubMed ID: 17999187
[TBL] [Abstract][Full Text] [Related]
13. Intervention effects of QRZSLXF, a Chinese medicinal herb recipe, on the DOR-β-arrestin1-Bcl2 signal transduction pathway in a rat model of ulcerative colitis.
Fan H; Liu XX; Zhang LJ; Hu H; Tang Q; Duan XY; Zhong M; Shou ZX
J Ethnopharmacol; 2014 May; 154(1):88-97. PubMed ID: 24637189
[TBL] [Abstract][Full Text] [Related]
14. Effect of heme oxygenase-1 induction by octreotide on TNBS-induced colitis.
Erbil Y; Giriş M; Abbasoğlu SD; Barbaros U; Yanik BT; Necefli A; Olgaç V; Toker GA
J Gastroenterol Hepatol; 2007 Nov; 22(11):1852-8. PubMed ID: 17914959
[TBL] [Abstract][Full Text] [Related]
15. Increased migration of IgA lymphocytes to VIP nerve fibers after DSS-induced colitis.
Ueno E; Hisajima T; Nakano M; Goris RC; Funakoshi K
Histol Histopathol; 2011 Oct; 26(10):1317-26. PubMed ID: 21870335
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of ginsenoside Rd in rats with TNBS-induced recurrent ulcerative colitis.
Yang XL; Guo TK; Wang YH; Gao MT; Qin H; Wu YJ
Arch Pharm Res; 2012 Jul; 35(7):1231-9. PubMed ID: 22864746
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
[TBL] [Abstract][Full Text] [Related]
18. Intestinal anti-inflammatory activity of the seeds of Raphanus sativus L. in experimental ulcerative colitis models.
Choi KC; Cho SW; Kook SH; Chun SR; Bhattarai G; Poudel SB; Kim MK; Lee KY; Lee JC
J Ethnopharmacol; 2016 Feb; 179():55-65. PubMed ID: 26721217
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease.
Mazumdar S; Das KM
Am J Gastroenterol; 1992 Feb; 87(2):176-81. PubMed ID: 1370872
[TBL] [Abstract][Full Text] [Related]
20. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis--a radioimmunoassay and immunohistochemical study.
Todorovic V; Janic B; Koko V; Micev M; Nikolic JA; Ratkovic M; Leposavic G; Jankovic T; Knezevic-Usaj S; Milicevic Z
Hepatogastroenterology; 1996; 43(9):483-8. PubMed ID: 8799381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
